Source-led article
Mykare Secures $3.2 Million to Boost AI Capabilities and Expand Healthcare Network
Indian healthtech startup Mykare has successfully closed its funding round at $3.2 million (₹30.2 Cr), following an additional $1 million (₹9.4 Cr) bridge investment. This new capital injection, which saw participation from Papa.com co-founders Andrew Parker and Alfredo Vaamonde, alongside a Middle-Eastern family office, is earmarked to significantly enhance Mykare’s AI capabilities, accelerate product development, and expand its operational footprint in existing international markets.
The funding builds on a $2.2 million seed round Mykare secured in 2023 from investors including OnDeck ODX and Avaana Seed. The company, founded in 2022 by Senu Sam, Rahmatulla TM, and Joash Philipose, initially focused on connecting patients with affordable hospital facilities. It later transitioned to a B2B model in October 2025, deploying an agentic AI and voice AI platform designed to help small and medium-sized hospitals and medical centers optimize sales, improve patient experience, and automate workflows.
AI-Powered Healthcare Automation
Mykare’s core offering is an AI-native healthcare operating system (OS) that automates the entire patient journey. This includes patient acquisition, appointment booking, feedback collection, and retention. The platform’s AI agents are designed to identify patient intent, handle calls through voice AI, schedule appointments, manage follow-ups, and automatically update customer relationship management (CRM) records.
According to co-founder Senu Sam, Mykare’s AI agents are currently integrated into 30-35 larger healthcare facilities, with an additional 45 clinics having signed up for implementation. The startup aims to onboard 100 clinics soon. Globally, Mykare has partnered with over 30 hospitals and clinics across the US, UK, the Middle East, and India, and reports a waiting list of more than 20 additional healthcare providers.
Market Presence and Expansion
In India, Mykare’s services are active in major metropolitan areas, including Delhi NCR, Mumbai, Bengaluru, and Hyderabad. Internationally, the company has established ties with a large oncology clinic chain and a significant dental chain in the UK. Discussions are also underway with one of the largest dental chains in Qatar, signaling further global expansion plans.
Key facts
| Feature | Detail |
|---|---|
| Total Funding | $3.2 million (₹30.2 Cr) |
| Latest Round | $1 million (₹9.4 Cr) bridge investment |
| Investors | Papa.com co-founders, Middle-Eastern family office (latest round) |
| Key Technology | AI-native healthcare OS, agentic AI, voice AI |
| Current Reach | 30-35 large facilities, 45+ clinics signed up, 30+ hospitals globally |
| Markets | India (metros), US, UK, Middle East |
The broader Indian healthtech ecosystem is experiencing rapid growth, moving beyond traditional healthcare services. Startups are increasingly leveraging AI for patient management, preventive healthcare, recovery, and stress management. This trend is fueled by rising consumer demand for integrated wellness platforms that encompass diagnostics, coaching, nutrition, and skincare. Investor interest in the sector has also surged, with recent funding rounds for companies like Hoola Health ($5 million) and Gabit (₹36.2 Cr).
Implications for Indian Healthcare and AI
This funding round for Mykare underscores the increasing adoption of AI and automation within the Indian healthcare sector. For AI News India readers, this development highlights how AI is being deployed to streamline complex patient journeys, improve operational efficiency for medical facilities, and potentially make healthcare more accessible and personalized. The focus on agentic AI and voice AI for tasks like appointment booking and follow-ups demonstrates practical applications of advanced AI in a critical service industry. As Mykare expands its network and enhances its AI capabilities, it contributes to the projected $37 billion opportunity for India’s homegrown healthtech sector by 2030.